Results 21 to 30 of about 801 (115)
Indian Journal of Psychological Medicine, 2014 Background: Despite a large body of evidence, the issue of differences in adherence and continuation of treatment with first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs) in schizophrenia remains unresolved.
Nisha Warikoo +2 more
doaj +1 more source
Second Generation Long-Acting Injectable Antipsychotics in Africa: About a Case
European Psychiatry, 2023 Introduction Schizophrenia affects people worldwide. In Europe, the advantages of second-generation and long-acting injectable antipsychotics (SG-LAIs) are known and used, supported by scientific evidence.
J. Galvañ, F. R. Nguepy-Keubo
doaj +1 more source
Indian Journal of Psychological Medicine, 2014 Background: Given the paucity of research in this area, this study attempted to assess attitudes toward antipsychotic medications and its correlates among patients with schizophrenia, either on first-generation antipsychotics (FGAs) or second-generation ...
M S Karthik +4 more
doaj +1 more source
Second-generation antipsychotics and metabolic syndrome: a role for mitochondria
Frontiers in Psychiatry, 2023 Psychosis is a known risk factor for developing metabolic syndrome (MetS). The risk is even greater in patients who are taking second-generation antipsychotics (SGAs).
Katherine R. H. Mortimer +3 more
doaj +1 more source
Intentional Recreational Abuse of Quetiapine Compared to Other Second-generation Antipsychotics
Western Journal of Emergency Medicine, 2017 Introduction: Case reports and poison center data have demonstrated that the second-generation antipsychotic quetiapine is being obtained and used for recreational abuse.
Lauren Klein, Stacey Bangh, Jon B. Cole
doaj +1 more source
Neutropenia induced by several second-generation antipsychotics :A case report
European Psychiatry, 2023 Introduction Antipsychotic medications remain the mainstay of the treatment of various psychiatric disorders, particularly schizophrenia. However, this therapeutic class can induce a range of side effects.
H. Zarouf +3 more
doaj +1 more source
Interactions between antiepileptics and second-generation antipsychotics
Expert Opinion on Drug Metabolism & Toxicology, 2012 Pharmacokinetic and pharmacodynamic drug interactions (DIs) can occur between antiepileptics (AEDs) and second-generation antipsychotics (SGAPs). Some AED and SGAP pharmacodynamic mechanisms are poorly understood. AED-SGAP combinations are used for treating comorbid illnesses or increasing efficacy, particularly in bipolar disorder.This article ...
de Leon J +3 more
openaire +4 more sources
A case of tardive dyskinesia with paliperidone palmitate
Telangana Journal of Psychiatry, 2015 Background: Tardive dyskinesia is a neurological side effect of long term antipsychotics use. Incidence is common and found to be less prevalent with second generation antipsychotics than the first generation antipsychotics.
Philip Kumar Boyanapally +2 more
doaj +1 more source
Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
Industrial Psychiatry Journal, 2022 Anti-psychotics are the mainstay of treatment for Schizophrenia and psychotic disorders. Historically, anticholinergics have been prescribed to prevent or treat extrapyramidal side effects (EPS) associated with first-generation antipsychotics (FGAs ...
Kaushik Chatterjee +5 more
doaj +1 more source
Second-Generation Antipsychotic Drugs for Children and Adolescents
Journal of Nippon Medical School, 2021 The effectiveness and safety of antipsychotics have not been fully established in children and adolescents. Many antipsychotics approved for use in adults are prescribed off-label to children and adolescents. We investigated the effectiveness and tolerability of antipsychotics for children and adolescents with schizophrenia and bipolar disorder.
Onishi, Yuichi +7 more
openaire +3 more sources